(주)한국비티비

Skip to main content Skip to main menu
Company

Company

We introduce the present and future of BTB Korea, built on people-centered and principle-driven management.

History

Medical

Bio

  • 1999
    • Corporate Establishment (GTG Wellness)
  • 2006
    • Selected as an "Innovative Company" by the Small and Medium Business Administration
  • 2009
    • Established Manufacturing Plant
  • 2007
    • Selected as a Management Innovation SME
    • Awarded the '$3 Million Export Tower'
  • 2010
    • Awarded the '$5 Million Export Tower'
  • 2012
    • Obtained Medical Device Manufacturing License
  • 2013
    • Certified as Venture Company / INNO-BIZ
    • Established Corporate R&D Center
    • Obtained KGMP Compliance Certification
  • 2014
    • Obtained Medical Device Manufacturing License for 'DEPILIGHT' and 'CARESYS'
    • Launched 'OPERA'
    • Launched 'Tulip FB', 'Ultratech', and 'Ulstam'
    • Obtained ISO 9001 Certification
    • Obtained ISO 13485 Certification
  • 2015
    • Obtained CB Certification for 'Tulip' and 'Ultratech'
  • 2016
    • Obtained CE MDD Certification for 'DEPILIGHT' and 'CICU'
    • Obtained European CE Certification for 'abas-CE'
    • Obtained CE MDD Certification for 'LESHAPE'
    • Launched 'LEBODY'
    • Launched 'LESHAPE'
    • Launched upgraded 'SMOOTH LINER'
  • 2017
    • Launched 'PICOHOLIC'
    • Launched 'DUAL HI'
  • 2018
    • Listed on KOSDAQ
    • Awarded the '$10 Million Export Tower'
    • Obtained CE MDD Certification for 'DUAL HI'
    • Awarded 'Industrial Technology of the Month' for 'DUAL HI'
    • Received the 'Minister of Trade, Industry and Energy Award'
  • 2019
    • Obtained CE MDD Certification for 'PICOHOLIC'
    • Obtained European CE Certification for 'abas-One'
    • Launched 'Opera Milux'
    • Established Headquarters Building
    • Launched 'DepiPlus'
  • 2020
    • Obtained European CE Certification for 'abas-Fit'
    • Obtained Taiwan TFDA Approval for 'PICOHOLIC'
  • 2021
    • Obtained Taiwan TFDA Approval for 'CICU'
    • Obtained MFDS Approval for 'Repotent'
  • 2023
    • Obtained Taiwan TFDA Approval for 'DUAL HI'
    • Signed M&A Agreement with Korea BNC Co., Ltd.
    1994 ~ 2004
    2005 ~ 2010
    2011 ~ 2013
    2014 ~ 2015
    2016 ~ 2017
    2018 ~ 2019
    2020 ~ 2023
    2024 ~
    • 1994
      • Founded Dongin Trading
    • 1996
      • Signed Exclusive Dealership Agreement with 'Duchefa'
    • 1999
      • Corporate Establishment (Dongin Biotech)
    • 2024
      • Signed Exclusive Dealership Agreement with 'RBC'
    • 2005
      • Established Headquarters Building
      • Signed Dealership Agreement with 'Echelon'
      • Signed Exclusive Dealership Agreement with 'Immunochemistry Technology'
    • 2007
      • Certified as a Management Innovation SME
    • 2008
      • Signed Exclusive Dealership Agreement with 'LifeSpan BioSciences (now Lsbio)'
      • Signed Dealership Agreement with 'Assay Designs (now Enzo)'
      • Signed Dealership Agreement with 'Bethyl'
    • 2009
      • Signed Dealership Agreement with 'ALPCO'
      • Signed Dealership Agreement with 'Bioworld'
    • 2010
      • Signed Dealership Agreement with 'Favorgen'
    • 2011
      • Signed Dealership Agreement with 'Mpbio'
    • 2012
      • Signed Dealership Agreement with 'Enzo Life Sciences'
    • 2013
      • Opened R&D Center
      • Established Gwangju Branch
    • 2015
      • Received Commissioner of the National Tax Service Award for Exemplary Taxpayer
    • 2016
      • Established Jeonju Branch Headquarters Building
    • 2017
      • Signed Exclusive Dealership Agreement with 'BPS Bioscience'
      • 2023
        • Acquired by Korea BNC Co., Ltd.
      • 2024
        • Merger of GTG Wellness and Dongin Biotech; Launch of Integrated Corporation
        • Changed Corporate Name to BTB Korea Co., Ltd.
        • Launched ITSPICO
      • 2025
        • Launched AI-Based Platform BTBmarket
      Medical Bio